Abstract:Abstract Background Covid-19 became a global pandemic in 2019. Studies have shown that coronavirus can cause neurological symptoms, but clinical studies on its neurological symptoms are limited. In this meta-analysis, we aimed to summarize the various neurological manifestations that occurred in COVID-19 patients and calculate the incidence of various neurological manifestations. At the same time, we further explored the mechanism of nervous system injury and prognosis in COVID-19 patients in combination with their nervous system manifestations. This study provides a reference for early clinical identification of COVID-19 nervous system injury in the future, so as to achieve early treatment and reduce neurological sequelae. Methods We systematically searched all published English literature related to the neurological manifestations of COVID-19 from January 1, 2020, to April 30, 2021, in Pubmed, Embase, and Cochrane Library. The keywords used were COVID-19 and terminology related to the nervous system performance. All included studies were selected by two independent reviewers using EndNote and NoteExpress software, any disagreement was resolved by consensus or by a third reviewer, and the selected data were then collected for meta-analysis using a random-effects model. Results A total of 168 articles (n = 292,693) were included in the study, and the meta-analysis showed that the most common neurological manifestations of COVID-19 were myalgia(33%; 95%CI 0.30–0.37; I 2 = 99.17%), smell impairment(33%; 95%CI 0.28–0.38; I 2 = 99.40%), taste dysfunction(33%; 95%CI 0.27–0.39; I 2 = 99.09%), altered mental status(32%; 95%CI 0.22–0.43; I 2 = 99.06%), headache(29%; 95%CI 0.25–0.33; I 2 = 99.42%), encephalopathy(26%; 95%CI 0.16–0.38; I 2 = 99.31%), alteration of consciousness(13%; 95%CI 0.08–0.19; I 2 = 98.10%), stroke(12%; 95%CI 0.08–0.16; I 2 = 98.95%), dizziness(10%; 95%CI 0.08–0.13; I 2 = 96.45%), vision impairment(6%; 95%CI 0.03–0.09; I 2 = 86.82%), intracerebral haemorrhage(5%; 95%CI 0.03–0.09; I 2 = 95.60%), seizure(4%; 95%CI 0.02 -0.05; I 2 = 98.15%), encephalitis(2%; 95%CI 0.01–0.03; I 2 = 90.36%), Guillan-Barré Syndrome (GBS) (1%; 95%CI 0.00–0.03; I 2 = 89.48%). Conclusions Neurological symptoms are common and varied in Covid-19 infections, and a growing number of reports suggest that the prevalence of neurological symptoms may be increasing. In the future, the role of COVID-19 neurological symptoms in the progression of COVID-19 should be further studied, and its pathogenesis and assessment methods should be explored, to detect and treat early neurological complications of COVID-19 and reduce mortality.

Neurological Complications of COVID-19 Infection: A Comprehensive Review

Neurological Complications of COVID-19: Unraveling the Pathophysiological Underpinnings and Therapeutic Implications

Neurological Complications of COVID-19: A Systematic Review of Literature

A Systematic Review Unraveling the Intricate Neurological Spectrum of COVID-19: Manifestations, Complications, and Transformative Insights for Patient Care

Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review

Acute and Post-Acute Neurological Complications of COVID-19

Neurologic aspects of covid-19: a concise review

Neurological Complications of COVID-19 and Possible Neuroinvasion Pathways: A Systematic Review

Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic

Neurological complications and COVID-19: A literature review

Neurological Involvement in COVID-19 and Potential Mechanisms: A Review

The Neurological Implications of COVID-19: A Comprehensive Narrative Review

Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)

Neurological Complications of Coronavirus Disease 2019 and the Underlying Mechanisms

A Comprehensive Review on Navigating the Neurological Landscape of COVID-19: Insights Into Etiopathogenesis and Clinical Management

Neurological manifestations of COVID-19: A potential gate to the determinants of a poor prognosis

Neurological complications caused by SARS-CoV-2

Neurological complications in COVID-19 - a diagnostic challenge

Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions

Persons with Co-Existing Neurological Disorders: Risk Analysis, Considerationsand Management in COVID-19 Pandemic

What can the neurological manifestations of COVID-19 tell us: a meta-analysis